Can you provide the last earnings date for BIOMARIN PHARMACEUTICAL INC?
BIOMARIN PHARMACEUTICAL INC (BMRN) last reported earnings on 2/23/2026.
BIOMARIN PHARMACEUTICAL INC (BMRN) Earnings History & Surprises
NASDAQ:BMRN • US09061G1013
Current stock price
56.3 USD
-0.9 (-1.57%)
At close:
56.3 USD
0 (0%)
After Hours:
BMRN Earnings overview
Past quarterly earnings results for BIOMARIN PHARMACEUTICAL INC (BMRN), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Apr 29, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.78
- Revenue Estimate
- 772.41M
Last Reported
Most Recent- Release Date
- Feb 23, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.24
- EPS Surprise
- -137.68%
- Revenue Surprise
- 3.57%
Beat Rate
Last 8 Quarters 69%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.24 | 0.64 | -137.68% | -137.50% | 874.565M | 844.44M | 3.57% | 17.03% |
| Q3 2025 | -0.16 | 0.38 | -142.18% | -129.09% | 776.133M | 796.24M | -2.53% | 4.08% |
| Q2 2025 | 1.23 | 0.85 | 44.44% | 119.64% | 825.41M | 775.18M | 6.48% | 15.92% |
| Q1 2025 | 0.95 | 0.72 | 31.48% | 106.52% | 745.145M | 755.53M | -1.37% | 14.84% |
| Q4 2024 | 0.64 | 0.54 | 18.42% | 255.56% | 747.313M | 727.71M | 2.69% | 15.65% |
| Q3 2024 | 0.55 | 0.53 | 4.22% | 161.90% | 745.74M | 714.18M | 4.42% | 28.28% |
| Q2 2024 | 0.56 | 0.36 | 57.23% | 93.10% | 712.029M | 675.29M | 5.44% | 19.61% |
| Q1 2024 | 0.46 | 0.35 | 30.72% | 70.37% | 648.833M | 664.82M | -2.40% | 8.79% |
| Q4 2023 | 0.18 | 0.24 | -24.46% | - | 646.207M | 649.62M | -0.53% | 20.22% |
| Q3 2023 | 0.21 | 0.24 | -12.05% | 625.00% | 581.329M | 620.85M | -6.37% | 15.05% |
| Q2 2023 | 0.29 | 0.24 | 22.09% | 93.33% | 595.275M | 607.14M | -1.95% | 11.52% |
| Q1 2023 | 0.27 | 0.18 | 47.54% | 50.00% | 596.415M | 582.04M | 2.47% | 14.83% |
| Q4 2022 | 0.00 | -0.07 | 100.00% | 100.00% | 537.5M | 547.71M | -1.86% | 19.50% |
| Q3 2022 | -0.04 | -0.01 | -361.36% | 80.00% | 505.3M | 528.78M | -4.44% | 23.64% |
| Q2 2022 | 0.15 | 0.12 | 29.99% | 114.29% | 533.8M | 531.9M | 0.36% | 6.40% |
| Q1 2022 | 0.18 | 0.18 | 2.52% | 100.00% | 519.4M | 517.67M | 0.33% | 6.87% |
| Q4 2021 | -0.32 | -0.33 | 2.37% | -366.67% | 449.8M | 451.23M | -0.32% | -0.51% |
| Q3 2021 | -0.20 | -0.25 | 20.94% | -104.99% | 408.7M | 444.03M | -7.96% | -14.28% |
| Q2 2021 | 0.07 | -0.12 | 158.23% | 450.00% | 501.7M | 457.47M | 9.67% | 16.81% |
| Q1 2021 | 0.09 | -0.07 | 231.05% | -79.55% | 486M | 455.38M | 6.72% | -3.21% |
| Q4 2020 | 0.12 | -0.19 | 161.70% | - | 452.1M | 449.03M | 0.68% | - |
| Q3 2020 | 4.01 | 1.26 | 218.06% | - | 476.8M | 463.74M | 2.82% | - |
| Q2 2020 | -0.02 | -0.10 | 79.94% | - | 429.5M | 426.99M | 0.59% | - |
| Q1 2020 | 0.44 | 0.05 | 723.70% | - | 502.1M | 478.15M | 5.01% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
-50.99%
Max EPS beat (4)
44.44%
Min EPS beat (4)
-142.18%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
1.54%
Max Revenue beat (4)
6.48%
Min Revenue beat (4)
-2.53%
Analysis
In the last 4 quarters, BMRN has beaten EPS estimates in 2 out of 4 releases
BMRN has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, BMRN reported -51.0% below the EPS estimates on average.
In the last 4 quarters, BMRN has beaten the revenue estimates by 1.5% on average.
Related analysis
BIOMARIN PHARMACEUTICAL INC / BMRN Earnings FAQ
Did BMRN stock beat earnings estimates in the most recent quarter?
BIOMARIN PHARMACEUTICAL INC (BMRN) missed EPS estimates and beat revenue estimates in the most recent quarter.
What percentage of the time does BMRN stock beat earnings estimates?
In the last 4 quarters, BIOMARIN PHARMACEUTICAL INC (BMRN) has beaten EPS estimates in 2 out of 4 releases.